Liquid Biopsy Marks The Progression Of Colorectal Cancer by Karishma Abhishek on February 16, 2021 at 10:42 AM
Liquid biopsy assessing the blood or urine samples may help monitor the effectiveness of cancer therapy for the initial phase of colorectal cancer metastasis (oligometastatic) as per a study from Washington University School of Medicine in St. Louis, published in the Journal of Clinical Oncology Precision Oncology, a journal of the American Society of Clinical Oncology. Oligometastatic colorectal cancer requires initial chemotherapy to shrink and remove the remains of the primary tumor before having surgery. Food and Drug Administration (FDA) has approved a few liquid biopsies for lung, breast, ovarian, and prostate cancers, but none has been approved for colorectal cancer.